BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15349864)

  • 1. Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception.
    Bartsch T; Knight YE; Goadsby PJ
    Ann Neurol; 2004 Sep; 56(3):371-81. PubMed ID: 15349864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamus.
    Bartsch T; Levy MJ; Knight YE; Goadsby PJ
    Pain; 2005 Sep; 117(1-2):30-9. PubMed ID: 16043293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans.
    Classey JD; Bartsch T; Goadsby PJ
    Brain Res; 2010 Nov; 1361():76-85. PubMed ID: 20833155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons.
    Donaldson C; Boers PM; Hoskin KL; Zagami AS; Lambert GA
    Neuropharmacology; 2002 Mar; 42(3):374-85. PubMed ID: 11897116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of 5-HT1B and 5-HT1D receptors in the rat nucleus tractus solitarius: opposing action on neurones that receive an excitatory vagal C-fibre afferent input.
    Jeggo RD; Wang Y; Jordan D; Ramage AG
    Br J Pharmacol; 2007 Apr; 150(8):987-95. PubMed ID: 17339842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
    Goadsby PJ; Hoskin KL
    Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine.
    Akerman S; Holland PR; Lasalandra MP; Goadsby PJ
    J Neurosci; 2013 Sep; 33(37):14869-77. PubMed ID: 24027286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midbrain control of spinal nociception discriminates between responses evoked by myelinated and unmyelinated heat nociceptors in the rat.
    McMullan S; Lumb BM
    Pain; 2006 Sep; 124(1-2):59-68. PubMed ID: 16650581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input.
    Goadsby PJ; Classey JD
    Neuroscience; 2003; 122(2):491-8. PubMed ID: 14614913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.
    Goadsby PJ; Knight Y
    Br J Pharmacol; 1997 Nov; 122(5):918-22. PubMed ID: 9384509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamospinal oxytocinergic antinociception is mediated by GABAergic and opiate neurons that reduce A-delta and C fiber primary afferent excitation of spinal cord cells.
    Condés-Lara M; Rojas-Piloni G; Martínez-Lorenzana G; López-Hidalgo M; Rodríguez-Jiménez J
    Brain Res; 2009 Jan; 1247():38-49. PubMed ID: 18996098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene-related peptide in the rat trigeminovascular system.
    Amrutkar DV; Ploug KB; Hay-Schmidt A; Porreca F; Olesen J; Jansen-Olesen I
    Pain; 2012 Apr; 153(4):830-838. PubMed ID: 22305629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents.
    Akerman S; Holland PR; Lasalandra MP; Goadsby PJ
    Headache; 2009 Sep; 49(8):1131-43. PubMed ID: 19719541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of neurons in the trigeminal nucleus caudalis responding to noxious dural and facial stimulation.
    Bolton S; O'Shaughnessy CT; Goadsby PJ
    Brain Res; 2005 Jun; 1046(1-2):122-9. PubMed ID: 15885666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat.
    Holland PR; Akerman S; Goadsby PJ
    Eur J Neurosci; 2006 Nov; 24(10):2825-33. PubMed ID: 17156207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the 5-HT1B/D receptor reduces hindlimb neurogenic inflammation caused by sensory nerve stimulation and capsaicin.
    Carmichael NM; Charlton MP; Dostrovsky JO
    Pain; 2008 Jan; 134(1-2):97-105. PubMed ID: 17499925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models.
    Bhatt DK; Gupta S; Jansen-Olesen I; Andrews JS; Olesen J
    Cephalalgia; 2013 Jan; 33(2):87-100. PubMed ID: 23155193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats.
    Liu FY; Xing GG; Qu XX; Xu IS; Han JS; Wan Y
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1046-53. PubMed ID: 17329553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA-mediated oxytocinergic inhibition in dorsal horn neurons by hypothalamic paraventricular nucleus stimulation.
    Rojas-Piloni G; López-Hidalgo M; Martínez-Lorenzana G; Rodríguez-Jiménez J; Condés-Lara M
    Brain Res; 2007 Mar; 1137(1):69-77. PubMed ID: 17229405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroanatomical approaches of the tectum-reticular pathways and immunohistochemical evidence for serotonin-positive perikarya on neuronal substrates of the superior colliculus and periaqueductal gray matter involved in the elaboration of the defensive behavior and fear-induced analgesia.
    Coimbra NC; De Oliveira R; Freitas RL; Ribeiro SJ; Borelli KG; Pacagnella RC; Moreira JE; da Silva LA; Melo LL; Lunardi LO; Brandão ML
    Exp Neurol; 2006 Jan; 197(1):93-112. PubMed ID: 16303128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.